WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.

Moderator

• 

• Barbara Rath, MD, PhD

  Co-founder and Chair
  Vaccine Safety Initiative
  USA/Germany
  Research Director
  University of Bourgogne Franche-Comte
  Besançon, France

  Disclosures

  Barbara Rath, MD, PhD, has the following relevant financial relationships:
  Consultant or advisor for: AstraZeneca Pharmaceuticals LP; GlaxoSmithKline (Data and Safety Monitoring Board chair); Roche

Faculty

• 

• Paolo Bonanni, MD

  Professor of Hygiene
  School of Medicine
  Director
  Department of Health Sciences University of Florence
  Florence, Italy

  Disclosures

  Paolo Bonanni, MD, has the following relevant financial relationships:
  Consultant or advisor for: AstraZeneca Pharmaceuticals LP; CSL Seqirus; GlaxoSmithKline; Janssen Pharmaceuticals; Merck Sharp & Dohme; Moderna, Inc.; Pfizer, Inc.; Sanofi Pasteur
  Speaker or member of speakers bureau for: AstraZeneca Pharmaceuticals LP; CSL Seqirus; GlaxoSmithKline; Janssen Pharmaceuticals; Merck Sharp & Dohme; Moderna, Inc.; Pfizer, Inc.; Sanofi Pasteur
  Research funding from: AstraZeneca Pharmaceuticals LP; CSL Seqirus; GlaxoSmithKline; Merck Sharp & Dohme; Pfizer, Inc.; Sanofi Pasteur

• 

• Federico Martinón-Torres, MD, PhD

  Head of Pediatrics
  Director
  Translational Pediatrics and Infectious Diseases
  Hospital Clínico Universitario de Santiago
  Coordinator
  Genetics Vaccines Infections and Pediatrics Research Group
  Healthcare Research Institute of Santiago de Compostela
  Santiago de Compostela, Spain

  Disclosures

  Federico Martinón-Torres, MD, PhD, has the following relevant financial relationships:
  Consultant or advisor for: Biofabri; GlaxoSmithKline; Janssen Pharmaceuticals; MedImmune Inc.; Merck Sharp & Dohme; Moderna, Inc.; Novavax, Inc.; Pfizer, Inc.; Sanofi
  Speaker or member of speakers bureau for: AstraZeneca Pharmaceuticals LP; CSL Seqirus; GlaxoSmithKline; Merck Sharp & Dohme; Moderna, Inc.; Pfizer, Inc.; Sanofi Pasteur
  Research funding from: GlaxoSmithKline; Merck Sharp & Dohme; Pfizer Inc.; Sanofi
  Other: Principal investigator of clinical trials for: Abbott; AstraZeneca Pharmaceuticals LP; CSL Seqirus; Cubist Pharmaceuticals; GlaxoSmithKline; MedImmune Inc.; Merck Sharp & Dohme; Novavax, Inc.; Pfizer, Inc.; Roche; Regeneron Pharmaceuticals, Inc.; Sanofi Pasteur

Editors

• Alessia Piazza, PhD

  Medical Education Director, WebMD Global, LLC

  Disclosures

  Alessia Piazza, PhD, has no relevant financial relationships.

• Diana Lucifero, PhD

  Scientific Content Manager, WebMD Global, LLC

  Disclosures

  Diana Lucifero, PhD, has no relevant financial relationships.

Compliance Reviewer

• Stephanie Corder, ND, RN, CHCP

  Associate Director, Accreditation and Compliance

  Disclosures

  Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.